<DOC>
	<DOC>NCT02863380</DOC>
	<brief_summary>The investigators hypothesize that personalizing the rTMS targets using functional MRI will increase its efficacy. The most dysfunctional regions or the most dysfunctional network will be stimulated homogeneously. Individualized rTMS will be compared to traditional rTMS procedure and to trans-cranial direct current stimulation (tDCS) in a randomized cross-over trial. In this pilot study the primary outcome measure will be the correction of the MRI anomalies. Symptoms reduction and the proportion of remitters will be secondary outcome measurements.</brief_summary>
	<brief_title>Personalized rTMS for Resistant Depression</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<criteria>Aged from 18 to 65 Y Affiliated to the health insurance Having signed an informed consent Suffering from major depression according to the DSM5 Unresponsive or incomplete remission after at least one trial of antidepressant (&gt; 6 weeks at efficient dose or side effects) Treatment stable for &gt; 6 weeks Contraindication for MRI, rTMS or tDCS: nonremovable ferromagnetic body, prosthesis, pacemaker, medication delivered by an implanted pump clip or vascular stent, heart valve or ventricular shunt, seizure disorders, skin pathology in the region of tDCS electrode placement. Pregnancy Severe and nonstabilized somatic pathology Patients deprived of liberty or hospitalized without their consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Individualized Medicine</keyword>
	<keyword>Transcranial Magnetic Stimulation, Repetitive</keyword>
	<keyword>Transcranial Direct Current Stimulation Monocentric</keyword>
	<keyword>Compariative Cross-Over 3 Arms Study Randomized, Single-Blind Method</keyword>
	<keyword>Functional Neuroimaging</keyword>
</DOC>